Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients
Status:
Terminated
Trial end date:
2018-05-05
Target enrollment:
Participant gender:
Summary
This is a Phase 1b/2a study investigating the safety and efficacy of Sym004, an
investigational medicinal product (IMP), in combination with FOLFIRI (chemotherapy) when
administered every second week (Q2W).